Fresh off a $120M deal with Big Pharma, Peninsula biotech seeks to raise another $69M
June 16, 2020 at 17:44 PM EDT
The company, which went public 13 months ago, is focused on an emerging way of attacking cancer, called "synthetic lethality."
